• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
13.44
17229.47
EPS(TTM)
Face Value()
Div & Yield %
71.55
2
0.52
 

As on: Jul 22, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
934.80 -27.15 70248 13.44
Stock Price Details
Open Price() 953.25
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 955.10
Today's Low () 927.40
52-Week High () 1226.1
152-Week Low () 789.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.52
Eps 71.55
Book Value 477.507017
Market Cap (.Cr) 17,229.47
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE987B01026


News
NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets
Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram
NATCO Pharma, Lupin secure USFDA approval for Eribulin Mesylate injection
Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection
Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter
Natco Pharma tanks after Q4 profit declines 34% YoY to Rs 268 cr
Natco Pharma Ltd leads losers in 'A' group
Natco Pharma to announce Quarterly Result
Stock Alert: Adani Ports, Natco Pharma, Gland Pharma, Allied Blenders, JSW Cement
Natco Pharma gains on Pomalidomide capsules launch in US
More
Corporate Details
Incoporation Year   : 1981
Chairman : V C Nannapaneni
Bussiness Group : Natco
Registered Office
Natco Pharma Ltd
Natco House,
Road No 2 Banjara Hills,
Hyderabad,
Telangana-500033
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-040-23547532
Fax:91-040-23548243
Fax:91-22-66317458
E-Mail : investors@natcopharma.co.in
URL : http://www.natcopharma.co.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • CNX SMALLCA
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi